Differential Efficacy of B-Ultrasound Combined with Molybdenum Target Detection Mode for Breast Cancer Staging and Correlation of Blood Flow Parameters with IGF-1 and IGF-2 Expression Level and Prognosis

<table class="table-group" id="tab7"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left" rowspan="2"></td><td class="align_center" colspan="2">Incidence of adverse outcome</td></tr><tr class="thead"><td class="align_center"><i>rs</i></td><td class="align_center"><i>P</i></td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">IGF-1</td><td class="align_center">0.735</td><td class="align_center">&lt;0.001</td></tr><tr><td class="align_left">IGF-2</td><td class="align_center">0.782</td><td class="align_center">&lt;0.001</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Correlation between IGF-1, IGF-2, and prognosis of breast cancer patients.</div>

Contrast Media & Molecular Imaging

tab7

Table 7

Table 7: Differential Efficacy of B-Ultrasound Combined with Molybdenum Target Detection Mode for Breast Cancer Staging and Correlation of Blood Flow Parameters with IGF-1 and IGF-2 Expression Level and Prognosis 

Table 7 | Differential Efficacy of B-Ultrasound Combined with Molybdenum Target Detection Mode for Breast Cancer Staging and Correlation of Blood Flow Parameters with IGF-1 and IGF-2 Expression Level and Prognosis 